AKI Therapeutics A/S — Credit Rating and Financial Key Figures
CVR number: 37509736
Slotsmarken 12, 2970 Hørsholm
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | |||||
Costs of management | -89.30 | - 707.18 | - 647.40 | - 492.06 | - 543.09 |
Other operating expenses | -1 157.30 | - 665.34 | -1 530.27 | -1 403.68 | |
EBIT | -89.30 | -1 864.48 | -1 312.74 | -2 022.33 | -1 946.77 |
Other financial income | 250.00 | 46.00 | |||
Other financial expenses | -10.47 | - 151.45 | -25.89 | -15.95 | - 280.69 |
Pre-tax profit | 150.23 | -2 015.93 | -1 338.63 | -1 992.29 | -2 227.46 |
Income taxes | -2.06 | 492.31 | 221.28 | 283.59 | 267.37 |
Net earnings | 148.17 | -1 523.62 | -1 117.35 | -1 708.69 | -1 960.09 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible rights | 1 123.76 | 1 048.84 | 973.93 | 875.53 | 802.57 |
Intangible assets total | 1 123.76 | 1 048.84 | 973.93 | 875.53 | 802.57 |
Other tangible assets | 163.37 | 290.77 | 422.16 | 694.58 | |
Tangible assets total | 163.37 | 290.77 | 422.16 | 694.58 | |
Investments total | |||||
Long term receivables total | |||||
Inventories total | |||||
Current other receivables | 49.13 | 179.34 | 148.83 | 186.11 | 300.54 |
Current deferred tax assets | 173.75 | 511.81 | 665.45 | 283.59 | 267.37 |
Short term receivables total | 222.88 | 691.15 | 814.29 | 469.70 | 567.91 |
Cash and bank deposits | 584.25 | 2 828.16 | 1 242.37 | 225.56 | 103.69 |
Cash and cash equivalents | 584.25 | 2 828.16 | 1 242.37 | 225.56 | 103.69 |
Balance sheet total (assets) | 1 930.89 | 4 731.53 | 3 321.36 | 1 992.95 | 2 168.76 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 50.00 | 75.00 | 525.00 | 525.00 | 525.00 |
Other reserves | 616.01 | 818.05 | 541.63 | 492.81 | 2 472.01 |
Retained earnings | - 698.94 | 4 203.20 | 2 506.00 | 1 437.47 | - 230.16 |
Profit of the financial year | 148.17 | -1 523.62 | -1 117.35 | -1 708.69 | -1 960.09 |
Shareholders equity total | 115.25 | 3 572.63 | 2 455.28 | 746.59 | 806.76 |
Non-current leasing loans | 82.89 | 147.54 | 214.20 | 352.43 | |
Provisions | 154.25 | ||||
Non-current deferred tax liabilities | 154.25 | ||||
Non-current liabilities total | 308.51 | 82.89 | 147.54 | 214.20 | 352.43 |
Current trade creditors | 422.64 | 884.07 | 324.93 | 517.21 | 581.67 |
Other non-interest bearing current liabilities | 1 238.74 | 191.94 | 393.61 | 514.95 | 427.89 |
Current liabilities total | 1 661.39 | 1 076.01 | 718.54 | 1 032.16 | 1 009.56 |
Balance sheet total (liabilities) | 2 085.14 | 4 731.53 | 3 321.36 | 1 992.95 | 2 168.76 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.